Mitochondrial DNA Defects
Mitochondrial DNA (mtDNA) defects are mutations in the small circular genome located within mitochondria, the organelles responsible for generating cellular energy through oxidative phosphorylation. These mutations disrupt the normal function of the electron transport chain and ATP synthesis, leading to insufficient energy production in affected cells. Because mitochondrial DNA is inherited exclusively from the mother, mitochondrial DNA defects follow a maternal inheritance pattern, meaning all children of an affected mother will inherit the mutation.
Cellular and Systemic Effects
The consequences of mtDNA defects vary depending on the specific mutation, the proportion of mutant mitochondria present in cells (heteroplasmy), and the energy demands of affected tissues. Tissues with high metabolic requirements—such as muscle, nerve, heart, and kidney—are particularly vulnerable to dysfunction. Clinical presentations can include progressive muscle weakness, neurological disorders, cardiac abnormalities, diabetes, deafness, and vision loss, often appearing in childhood or early adulthood.
Common Mutations and Diagnosis
Certain mtDNA mutations are associated with well-characterized syndromes, including MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) and MERRF (myoclonic epilepsy with ragged red fibers). Diagnosis typically involves genetic sequencing of mtDNA, muscle biopsy showing ragged red fibers, and assessment of lactate accumulation. Currently, no cure exists for mtDNA defects, though supportive treatments and emerging therapies aim to manage symptoms and slow disease progression.